Today, the WHO has listed two versions of the AstraZeneca / Oxford COVID-19 vaccine for emergency use, giving the green light for these vaccines to be deployed globally via COVAX. The vaccines are produced by AstraZeneca-SKBio (Republic of Korea) and the Serum Institute of India.
The WHO Emergency Use List (EUL) assesses the quality, safety and efficacy of COVID-19 vaccines and is a prerequisite for the vaccine supply to the COVAX center. It also allows countries to speed up their own regulatory approval to import and administer COVID-19 vaccines.
“Countries without access to vaccines to date will finally be able to start immunizing their health workers and populations at risk, thus contributing to the COVAX Centre’s objective of equitable distribution of vaccines,” said Dr Mariângela Simão , WHO Assistant Director-General for Access to Medicines. and health products.
“But we have to …
News Highlights Finance
- Headline: WHO lists two more COVID-19 vaccines for emergency use and COVAX deployment
- Check all news and articles from the Health news information updates.